Bio Analysis
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
The number of women getting recommended cervical cancer screenings is declining, according to data from Cedar Gate Technologies’ proprietary Nat...
January 18, 2024 | Analysis
In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...
December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific
To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...
July 24, 2023 | News
Industry leaders rate capabilities in five key areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government poli...
June 20, 2023 | Analysis
Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. GAAP net income of $302...
May 24, 2023 | News
ATTR-CM is caused by unstable transthyretin proteins that misfold and aggregate into amyloid fibrils that build up in the heart and other parts of the body...
May 12, 2023 | Analysis
Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...
May 03, 2023 | Opinion
This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...
April 07, 2023 | News
Research and Markets, a leading market research company, has released a report on the Australia Diabetes Market projecting it to reach ...
April 02, 2023 | News
Singapore: A Biopharma Hub Singapore is one of the most prominent players in the Southeast Asian biopharma industry. It has positioned itself as a hub for...
March 31, 2023 | News
Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compare...
March 31, 2023 | Company results
Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...
March 29, 2023 | News
2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...
March 23, 2023 | News
Most Read
Bio Jobs
News
Editor Picks